United States
老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
来凯医药-B
11.460
+0.160
1.42%
手动刷新
成交量:
124.70万
成交额:
1,443.54万
市值:
46.76亿
市盈率:
-15.16
高:
11.960
开:
11.540
低:
11.220
收:
11.300
数据加载中...
总览
公司
新闻
公告
来凯医药-B04月17日主力净流入26万元 散户资金抛售
市场透视
·
04-17
来凯医药-B盘中异动 股价大涨5.49%报11.920港元
市场透视
·
04-17
来凯医药-B04月16日主力净流出161万元 散户资金买入
市场透视
·
04-16
来凯医药-B盘中异动 股价大涨5.83%报12.700港元
市场透视
·
04-15
来凯医药-B04月14日获主力加仓141万元
市场透视
·
04-14
港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%
智通财经
·
04-14
【港股医药股多数走强 再鼎医药涨超13%】截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。
金融界
·
04-14
来凯医药-B盘中异动 早盘股价大涨5.26%报11.200港元
市场透视
·
04-14
来凯医药-B04月11日获主力加仓96万元
市场透视
·
04-11
港股异动 | 创新药概念走势强劲 乐普生物-B(02157)涨超18% 来凯医药-B(02105)涨超16%
智通财经
·
04-11
来凯医药-B(02105)股价显著上升14.378%,现价港币$10.66
阿斯达克财经
·
04-11
来凯医药-B盘中异动 股价大涨5.36%
市场透视
·
04-11
来凯医药-B04月10日主力净流入32万元 散户资金抛售
市场透视
·
04-10
来凯医药-B04月09日遭主力抛售54万元
市场透视
·
04-09
来凯医药-B盘中异动 急速跳水5.38%报8.970港元
市场透视
·
04-09
来凯医药-B盘中异动 大幅拉升8.57%报9.880港元
市场透视
·
04-08
来凯医药-B04月07日遭主力抛售893万元
市场透视
·
04-07
来凯医药-B盘中异动 大幅跳水5.40%报13.320港元
市场透视
·
04-03
来凯医药-B03月31日主力净流出153万元 散户资金买入
市场透视
·
03-31
来凯医药-B(02105):LAE102针对肥胖症治疗的IND临床方案修订版已递交美国FDA
智通财经
·
03-31
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02105/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":11.46,"timestamp":1744877289031,"preClose":11.3,"halted":0,"volume":1247000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.7560241273067456,"marketStatus":"休市中","change":0.16,"latestTime":"04-17 16:08:09","open":11.54,"high":11.96,"low":11.22,"amount":14435375,"amplitude":0.065487,"askPrice":11.52,"askSize":500,"bidPrice":11.46,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.7560241273067456,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":11.3,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.5022757481996416,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.08%","roe":"-31.61%","lyrEps":-0.756024,"volumeRatio":0.5022757481996416,"shares":408000000,"dividePrice":0,"high":11.96,"amplitude":0.065487,"preClose":11.3,"low":11.22,"week52Low":3.9,"pbRate":"5.46","psRate":"8392.43","week52High":17.78,"institutionHeld":0,"latestPrice":11.46,"committee":0.333333,"eps":-0.7560241273067456,"divideRate":0,"volume":1247000,"delay":0,"ttmEps":-0.7560241273067456,"open":11.54,"prevYearClose":9.37,"prevWeekClose":10.64,"prevMonthClose":14.48,"prevQuarterClose":14.48,"fiveDayClose":9.32,"twentyDayClose":13.8,"sixtyDayClose":9.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528373796","title":"来凯医药-B04月17日主力净流入26万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528373796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528373796?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 16:15","pubTimestamp":1744877716,"startTime":"0","endTime":"0","summary":"04月17日, 来凯医药-B股价涨1.42%,报收11.46元,成交金额1443万元,换手率0.31%,振幅6.55%,量比0.50。来凯医药-B今日主力资金净流入26万元,上一交易日主力净流出161万元。该股近5个交易日上涨22.75%,主力资金累计净流入292万元;近20日主力资金累计净流出216万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417165932a6bdb3b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417165932a6bdb3b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2528782169","title":"来凯医药-B盘中异动 股价大涨5.49%报11.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528782169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528782169?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 09:36","pubTimestamp":1744853785,"startTime":"0","endTime":"0","summary":"2025年04月17日早盘09时36分,来凯医药-B股票出现异动,股价快速上涨5.49%。截至发稿,该股报11.920港元/股,成交量7.05万股,换手率0.02%,振幅3.72%。资金方面,该股资金流入20.457万港元,流出40.465万港元。来凯医药-B股票所在的生物技术行业中,整体跌幅为0.95%。其相关个股中,来凯医药-B、云康集团、映恩生物-B涨幅较大,振幅较大的相关个股有映恩生物-B、康诺亚-B、巨子生物,振幅分别为7.05%、6.36%、5.02%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041709362594d815f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041709362594d815f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2527734264","title":"来凯医药-B04月16日主力净流出161万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527734264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527734264?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 16:16","pubTimestamp":1744791381,"startTime":"0","endTime":"0","summary":"04月16日, 来凯医药-B股价跌9.02%,报收11.30元,成交金额3248万元,换手率0.69%,振幅11.59%,量比1.01。来凯医药-B今日主力资金净流出161万元,上一交易日主力净流入188万元。该股近5个交易日上涨23.09%,主力资金累计净流入298万元;近20日主力资金累计净流入16万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173748a45aeb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173748a45aeb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2527018361","title":"来凯医药-B盘中异动 股价大涨5.83%报12.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527018361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527018361?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 10:15","pubTimestamp":1744683319,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘10时15分,来凯医药-B股票出现异动,股价大幅拉升5.83%。截至发稿,该股报12.700港元/股,成交量54.15万股,换手率0.13%,振幅5.00%。资金方面,该股资金流入425.249万港元,流出191.54万港元。来凯医药-B股票所在的生物技术行业中,整体涨幅为0.75%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101520aa2c6f45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101520aa2c6f45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2527213438","title":"来凯医药-B04月14日获主力加仓141万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527213438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527213438?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 16:16","pubTimestamp":1744618577,"startTime":"0","endTime":"0","summary":"04月14日, 来凯医药-B股价涨12.78%,报收12.00元,成交金额2968万元,换手率0.61%,振幅13.91%,量比0.68。来凯医药-B今日主力资金净流入141万元,连续3日净流入,上一交易日主力净流入96万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为50.00%,平均涨幅为7.35%。该股近5个交易日上涨32.75%,主力资金累计净流入172万元;近20日主力资金累计净流出84万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171038a4584b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171038a4584b14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2527949291","title":"港股异动 | 医药股涨幅居前 再鼎医药(09688)涨近15% 和铂医药-B(02142)涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527949291","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527949291?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 09:57","pubTimestamp":1744595830,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医药股早盘涨幅居前,截至发稿,再鼎医药涨14.86%,报25.5港元;和铂医药-B涨10.07%,报7.87港元;荣昌生物涨8.22%,报30.95港元;君实生物涨8.1%,报15.22港元;来凯医药-B涨7.71%,报11.46港元。此外,财报层面:头部港股创新药公司受益于License-out放量,营收和利润稳步增长。该行表示,年初以来在DeepSeek的激励下,港股市场交投情形改善显著,相比之下,港股医药板块的关注度并不算高,对医药的基本面修复,市场定价或尚不充分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161","159938","LU2328871848.SGD","BK1588","BK4531","09939","09995","BK1515","LU1969619763.USD","ZLAB","09688","BK4548","BK4588","BK1583","BK1574","LU2488822045.USD","01877","BK4585","BK4526","02142","BK4139"],"gpt_icon":0},{"id":"2527945435","title":"【港股医药股多数走强 再鼎医药涨超13%】截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527945435","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527945435?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 09:42","pubTimestamp":1744594975,"startTime":"0","endTime":"0","summary":"截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14094249513998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK4531","BK4526","LU2488822045.USD","BK4139","BK1588","02137","02616","BK4585","SG9999014674.SGD","BK4588","BK1574","BK4548","BK1161","02268","09688","159718","02105","ZLAB","BK1587"],"gpt_icon":0},{"id":"2527943602","title":"来凯医药-B盘中异动 早盘股价大涨5.26%报11.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527943602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527943602?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 09:34","pubTimestamp":1744594452,"startTime":"0","endTime":"0","summary":"2025年04月14日早盘09时34分,来凯医药-B股票出现波动,股价急速上涨5.26%。截至发稿,该股报11.200港元/股,成交量2.2万股,换手率0.01%,振幅2.26%。资金方面,该股资金流入9.539万港元,流出5530港元。来凯医药-B股票所在的生物技术行业中,整体涨幅为1.47%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414093412aa2c6d77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414093412aa2c6d77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526815637","title":"来凯医药-B04月11日获主力加仓96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526815637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526815637?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 16:16","pubTimestamp":1744359405,"startTime":"0","endTime":"0","summary":"04月11日, 来凯医药-B股价涨14.16%,报收10.64元,成交金额2782万元,换手率0.65%,振幅21.03%,量比0.70。来凯医药-B今日主力资金净流入96万元,上一交易日主力净流入32万元。该股近5个交易日下跌17.70%,主力资金累计净流出862万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出229万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170833a455f54b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170833a455f54b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526103682","title":"港股异动 | 创新药概念走势强劲 乐普生物-B(02157)涨超18% 来凯医药-B(02105)涨超16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526103682","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526103682?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 15:29","pubTimestamp":1744356573,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,创新药概念走势强劲,截至发稿,乐普生物-B涨18.13%,报4.3港元;来凯医药-B涨16.74%,报10.88港元;康方生物涨11.6%,报82.75港元;和铂医药-B涨11.9%,报7.24港元;信达生物涨9.73%,报47.95港元。坚守中国创新药,短期可关注国产替代受益品种和内需产品。兴业证券认为,近期,创新药领域催化剂不断,包括海外授权、国内政策和临床数据进展等。预计和去年相比今年国产创新药重要数据将较多,有望为创新药板块带来正面催化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","02142","BK1574","LU0348784397.USD","02105","LU0417516571.SGD","LU2488822045.USD","02157","09926","159992","LU1720050803.USD","LU1794554557.SGD","01801","LU0348783233.USD","LU1969619763.USD","IE00B5MMRT66.SGD","BK1589","BK1161","06978","LU2328871848.SGD","BK1583","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2526746681","title":"来凯医药-B(02105)股价显著上升14.378%,现价港币$10.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2526746681","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526746681?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 14:55","pubTimestamp":1744354500,"startTime":"0","endTime":"0","summary":"[上升股]来凯医药-B(02105) 股价在下午02:55比前收市价显著上升14.378%,现股价为港币$10.66。至目前为止,今日最高价为$10.66,而最低价为$9.32。总成交量为135.2万股,总成交金额为港币$1.364千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2504114206/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526505580","title":"来凯医药-B盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526505580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526505580?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 11:36","pubTimestamp":1744342584,"startTime":"0","endTime":"0","summary":"2025年04月11日临近午盘11时36分,来凯医药-B股票出现波动,股价急速拉升5.36%。截至发稿,该股报9.820港元/股,成交量26.85万股,换手率0.07%,振幅5.36%。来凯医药-B股票所在的生物技术行业中,整体涨幅为1.26%。其相关个股中,和铂医药-B、康方生物、创胜集团-B涨幅较大,振幅较大的相关个股有和铂医药-B、康方生物、同源康医药-B,振幅分别为16.69%、12.74%、12.62%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041111362494d27586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041111362494d27586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526539519","title":"来凯医药-B04月10日主力净流入32万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526539519","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526539519?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 16:15","pubTimestamp":1744272933,"startTime":"0","endTime":"0","summary":"04月10日, 来凯医药-B股价涨1.53%,报收9.32元,成交金额2552万元,换手率0.64%,振幅11.11%,量比0.76。来凯医药-B今日主力资金净流入32万元,上一交易日主力净流出54万元。该股近5个交易日下跌33.81%,主力资金累计净流出1041万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出241万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410170305a454b609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410170305a454b609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526332366","title":"来凯医药-B04月09日遭主力抛售54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526332366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526332366?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 16:16","pubTimestamp":1744186597,"startTime":"0","endTime":"0","summary":"04月09日, 来凯医药-B股价跌3.16%,报收9.18元,成交金额3676万元,换手率1.01%,振幅14.56%,量比1.17。来凯医药-B今日主力资金净流出54万元,连续5日净流出,上一交易日主力净流出45万元。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为75.00%,平均跌幅为6.73%。该股近5个交易日下跌37.19%,主力资金累计净流出1127万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1239万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170854a4538913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170854a4538913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2526872715","title":"来凯医药-B盘中异动 急速跳水5.38%报8.970港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526872715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526872715?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 09:31","pubTimestamp":1744162266,"startTime":"0","endTime":"0","summary":"2025年04月09日早盘09时31分,来凯医药-B股票出现波动,股价大幅下跌5.38%。截至发稿,该股报8.970港元/股,成交量4.8万股,换手率0.01%,振幅7.17%。资金方面,该股资金流入0港元,流出31.4145万港元。来凯医药-B股票所在的生物技术行业中,整体跌幅为2.98%。其相关个股中,云康集团、华康生物医学、中生北控生物科技涨幅较大,振幅较大的相关个股有科伦博泰生物-B、复宏汉霖、维亚生物,振幅分别为11.88%、7.85%、7.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504090931069732972e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504090931069732972e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2525000992","title":"来凯医药-B盘中异动 大幅拉升8.57%报9.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525000992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525000992?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 09:30","pubTimestamp":1744075819,"startTime":"0","endTime":"0","summary":"2025年04月08日早盘09时30分,来凯医药-B股票出现异动,股价急速上涨8.57%。截至发稿,该股报9.880港元/股,成交量2000股,换手率0.00%,振幅8.57%。资金方面,该股资金流入4940港元,流出0港元。来凯医药-B股票所在的生物技术行业中,整体涨幅为1.64%。其相关个股中,来凯医药-B、药明合联、腾盛博药-B涨幅较大,振幅较大的相关个股有来凯医药-B、腾盛博药-B、和铂医药-B,振幅分别为8.57%、7.59%、5.52%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408093020a4519a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408093020a4519a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2525094553","title":"来凯医药-B04月07日遭主力抛售893万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525094553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525094553?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 16:16","pubTimestamp":1744013799,"startTime":"0","endTime":"0","summary":"04月07日, 来凯医药-B股价跌29.35%,报收9.10元,成交金额6935万元,换手率1.70%,振幅19.18%,量比2.65。来凯医药-B今日主力资金净流出893万元,连续3日净流出,上一交易日主力净流出83万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为62.50%,平均跌幅为4.45%。该股近5个交易日下跌37.41%,主力资金累计净流出836万元;近20日主力资金累计净流出349万元,其中净流出天数为12日。该股主力净额占比0.24%,港股市场排名2589/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170857a450a9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170857a450a9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2524472612","title":"来凯医药-B盘中异动 大幅跳水5.40%报13.320港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524472612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524472612?lang=zh_cn&edition=fundamental","pubTime":"2025-04-03 11:20","pubTimestamp":1743650455,"startTime":"0","endTime":"0","summary":"2025年04月03日早盘11时20分,来凯医药-B股票出现异动,股价大幅跳水5.40%。截至发稿,该股报13.320港元/股,成交量94.75万股,换手率0.23%,振幅8.38%。资金方面,该股资金流入354.722万港元,流出851.936万港元。来凯医药-B股票所在的生物技术行业中,整体跌幅为1.70%。其相关个股中,帝王国际投资、中国抗体-B、正大企业国际涨幅较大,振幅较大的相关个股有帝王国际投资、同源康医药-B、歌礼制药-B,振幅分别为17.24%、13.68%、12.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403112055972d0cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403112055972d0cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2523499293","title":"来凯医药-B03月31日主力净流出153万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2523499293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523499293?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 16:16","pubTimestamp":1743408961,"startTime":"0","endTime":"0","summary":"03月31日, 来凯医药-B股价跌0.41%,报收14.48元,成交金额2607万元,换手率0.45%,振幅8.94%,量比0.64。来凯医药-B今日主力资金(超大单+大单)净流出153万元,上一交易日主力净流入3万元。该股近5个交易日上涨3.72%,主力资金累计净流入352万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入3039万元,其中净流入天数为10日。该股主力净额占比0.03%(主力资金净额/流通市值),港股市场排名2411/2651。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165655a4485548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165655a4485548&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2523933370","title":"来凯医药-B(02105):LAE102针对肥胖症治疗的IND临床方案修订版已递交美国FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2523933370","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523933370?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 08:12","pubTimestamp":1743379953,"startTime":"0","endTime":"0","summary":"智通财经APP讯,来凯医药-B 发布公告,本集团已就LAE102针对肥胖症治疗适应症,向美国食品药品监督管理局提交新药临床试验申请临床方案修订版。2024年4月,LAE102获得美国FDA的IND批准,用于治疗肥胖症患者。2024年11月,本集团与礼来公司(礼来)签订一项临床合作协议,旨在支持和加速LAE102针对肥胖症治疗的全球临床开发。礼来将负责在美国执行一项I期研究并承担相关费用。本集团保留LAE102的全球权益。美国I期临床试验预计将于2025年第二季度启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1271263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-04-17","current":-15.831036,"percent":0.067265,"low":-20.235293,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"high":-1.640852,"avg":-8.190906,"sd":4.277952,"marketCap":4281657466},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466}],"updateTime":1745050127679}}}